Benson Radiology, a major private radiology network in South Australia, has been quietly on the block for some time through a global investment bank as doctor‑owners looked for a way to unlock value while keeping the business growing. The group runs more than 30 clinics across the state and is staffed by over 55 radiologists, making it one of the largest doctor‑partner owned radiology practices in the country. Interest from financial sponsors has been strong, reflecting a broader push by investors into diagnostic imaging and other healthcare platforms that promise steady demand and room for consolidation.
The path to this deal has not been smooth. An earlier plan to sell Benson Radiology to another institutional investor for more than $400m fell over, reportedly due to tensions involving doctors at Benson and issues inside that investor’s broader healthcare portfolio. For a time, expectations dropped, with some in the market thinking the business might now change hands for around $330m. Instead Crescent Capital has come back to the table and is understood to have agreed a price closer to $400m, supported by Benson Radiology’s reported annual revenue of about $100m and earnings before interest, tax, depreciation and amortisation of roughly $30m. Industry observers see Crescent’s move as part of a familiar playbook. It previously built a pathology and diagnostics platform that floated at an $800m valuation, which allowed Crescent to exit hundreds of millions of dollars worth of stock over time.
The broader picture is a healthcare sector that appears to be steadily concentrating under private equity and institutional ownership, even as some doctor groups push back. Crescent has been active across healthcare and related services, from dental networks to glass and building products although not every bid has succeeded and it has walked away from at least one contested acquisition. In radiology the Benson deal lands soon after another South Australian radiology group used contractual rights to block a private equity approach for a business generating around $150m in yearly revenue, which shows that not all medical practices are ready to cede control. At the same time wealth management and advisory platforms are also changing hands, with one financial group recently returning a long‑standing advice business to its adviser base ahead of a planned shareholder vote on a separate private equity buyout. Taken together, investor appetite for scalable, cash generating platforms remains strong but the final shape of ownership in healthcare and financial services will depend heavily on how practitioner‑owners respond to the next wave of bids.
